AT312595B - Verfahren zur Herstellung von neuen Indolverivaten und ihren Salzen - Google Patents

Verfahren zur Herstellung von neuen Indolverivaten und ihren Salzen

Info

Publication number
AT312595B
AT312595B AT7772A AT7772A AT312595B AT 312595 B AT312595 B AT 312595B AT 7772 A AT7772 A AT 7772A AT 7772 A AT7772 A AT 7772A AT 312595 B AT312595 B AT 312595B
Authority
AT
Austria
Prior art keywords
salts
production
indole derivatives
new indole
new
Prior art date
Application number
AT7772A
Other languages
English (en)
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Application granted granted Critical
Publication of AT312595B publication Critical patent/AT312595B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/38Oxygen atoms in positions 2 and 3, e.g. isatin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
AT7772A 1971-01-11 1972-01-05 Verfahren zur Herstellung von neuen Indolverivaten und ihren Salzen AT312595B (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB125071*[A GB1366133A (en) 1971-01-11 1971-01-11 Fused ring indole derivatives
GB4095971 1971-09-02
GB5646771 1971-12-06

Publications (1)

Publication Number Publication Date
AT312595B true AT312595B (de) 1974-01-10

Family

ID=27253859

Family Applications (1)

Application Number Title Priority Date Filing Date
AT7772A AT312595B (de) 1971-01-11 1972-01-05 Verfahren zur Herstellung von neuen Indolverivaten und ihren Salzen

Country Status (20)

Country Link
JP (1) JPS5531156B2 (de)
AR (1) AR192734A1 (de)
AT (1) AT312595B (de)
AU (1) AU464388B2 (de)
BE (1) BE777911A (de)
CA (1) CA1012150A (de)
CH (1) CH573938A5 (de)
CY (1) CY926A (de)
DK (1) DK150143C (de)
EG (1) EG10888A (de)
ES (2) ES398678A1 (de)
FI (1) FI54120C (de)
FR (1) FR2121699B1 (de)
GB (1) GB1366133A (de)
HK (1) HK52877A (de)
IE (1) IE35956B1 (de)
KE (1) KE2777A (de)
MY (1) MY7800048A (de)
NL (1) NL174251C (de)
SE (1) SE398645B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1520611A (en) * 1976-06-11 1978-08-09 Wyeth John & Brother Ltd Fused ring indole derivatives
JPS5845741B2 (ja) * 1977-06-06 1983-10-12 株式会社日立製作所 情報検索装置
ZA824382B (en) * 1981-07-07 1984-02-29 Wyeth John & Brother Ltd Anti-obesity agents
JPS60204057A (ja) * 1984-03-28 1985-10-15 Casio Comput Co Ltd デ−タ記憶機能付小型電子機器
GB8606253D0 (en) * 1986-03-13 1986-04-16 Wyeth John & Brother Ltd Pyrimidoindoles
GB8606254D0 (en) * 1986-03-13 1986-04-16 Wyeth John & Brother Ltd Substituted pyrimidoindoles
GB8614246D0 (en) * 1986-06-11 1986-07-16 Wyeth John & Brother Ltd Substituted pyrimidoindoles
WO2010090680A1 (en) * 2008-12-15 2010-08-12 Wyeth Llc Substituted oxindole cb2 agonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3888846A (en) * 1967-03-30 1975-06-10 Hoffmann La Roche Process for 2(2-(1,3-diazacycloalk-2-enyl))benzophenone derivatives and 1,3-diazacycloalkenyl(2,1-a)isoindole derivatives
US3586693A (en) * 1969-07-07 1971-06-22 American Home Prod Imidazo(1,2-a)indolin-9-ols

Also Published As

Publication number Publication date
FR2121699B1 (de) 1975-08-01
JPS5531156B2 (de) 1980-08-15
AR192734A1 (es) 1973-03-14
IE35956L (en) 1972-07-11
DK150143C (da) 1987-06-01
AU3755872A (en) 1973-07-05
IE35956B1 (en) 1976-07-07
JPS4839500A (de) 1973-06-09
CH573938A5 (de) 1976-03-31
SE398645B (sv) 1978-01-09
FR2121699A1 (de) 1972-08-25
BE777911A (fr) 1972-07-11
NL174251B (nl) 1983-12-16
MY7800048A (en) 1978-12-31
ES409296A1 (es) 1976-03-16
FI54120C (fi) 1978-10-10
AU464388B2 (en) 1975-08-28
KE2777A (en) 1977-10-21
CY926A (en) 1977-12-23
NL174251C (nl) 1984-05-16
ES398678A1 (es) 1975-05-16
FI54120B (fi) 1978-06-30
HK52877A (en) 1977-10-20
GB1366133A (en) 1974-09-11
CA1012150A (en) 1977-06-14
EG10888A (en) 1978-06-30
NL7200415A (de) 1972-07-13
DK150143B (da) 1986-12-15

Similar Documents

Publication Publication Date Title
AT311337B (de) Verfahren zur Herstellung von neuen Imidazolderivaten und ihren Salzen
AT316544B (de) Verfahren zur Herstellung von neuen Imidazolderivaten und ihren Salzen
AT302287B (de) Verfahren zur Herstellung von neuen Pyrrolinderivaten und ihren Salzen
AT305276B (de) Verfahren zur Herstellung von neuen Isoindolinderivaten und ihren Salzen
AT303041B (de) Verfahren zur Herstellung von neuen Isochinolin-Derivaten und ihren Salzen
AT321292B (de) Verfahren zur Herstellung von neuen Isoindolinderivaten und ihren Salzen
AT315831B (de) Verfahren zur Herstellung von neuen 4-Aza-benzimidazolderivaten und ihren Salzen
AT303022B (de) Verfahren zur Herstellung von neuen Dihydrofuranderivaten und ihren Salzen
AT312595B (de) Verfahren zur Herstellung von neuen Indolverivaten und ihren Salzen
AT333273B (de) Verfahren zur herstellung von neuen indazolderivaten und ihren salzen
AT303721B (de) Verfahren zur Herstellung von neuen Dishenylmethyl-imidazolen und ihren Salzen
AT310153B (de) Verfahren zur Herstellung von neuen Indolderivaten und ihren Salzen
AT320658B (de) Verfahren zur Herstellung von neuen Phthalazonderivaten und von ihren Salzen
AT302289B (de) Verfahren zur Herstellung von neuen Indolderivaten und ihren Salzen
AT313892B (de) Verfahren zur Herstellung von neuen Benzofuranderivaten und ihren Salzen
AT312594B (de) Verfahren zur Herstellung von neuen Indolderivaten und ihren Salzen
AT319231B (de) Verfahren zur Herstellung von neuen Pyrazolderivaten und ihren Salzen
AT312596B (de) Verfahren zur Herstellung von neuen Indolderivaten und ihren Salzen
AT304529B (de) Verfahren zur Herstellung von neuen Pyrrolderivaten und ihren Salzen
AT312600B (de) Verfahren zur Herstellung von neuen 5-Nitrothiazolderivaten und ihren Salzen
AT313891B (de) Verfahren zur Herstellung von neuen Pyrollinonderivaten und ihren Salzen
AT309420B (de) Verfahren zur Herstellung von neuen Thiazolderivaten und ihren Salzen
AT324321B (de) Verfahren zur herstellung von neuen iscindolinderivaten und ihren salzen
AT300778B (de) Verfahren zur Herstellung von neuen Pyrrolidinderivaten und ihren Salzen
AT318611B (de) Verfahren zur Herstellung von neuen Tioxanthenderivaten und ihren Salzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee